Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Drugs Dermatol ; 22(5): 507-508, 2023 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-37133471

RESUMEN

BACKGROUND: Intralesional 5-fluorouracil (5-FU) is a promising, yet sparsely studied alternative to surgical treatment for nonmelanoma skin cancer (NMSC).1 Previous studies of intralesional 5-FU have reported concentrations ranging from 30 to 50 mg/mL. To the best of our knowledge, this case series represents the first reported use of intralesional 5-FU 10.0 mg/mL and 16.7 mg/mL for NMSC. METHODS: A retrospective chart review identified 11 patients who received intralesional 5-FU 10.0 mg/mL and 16.7 mg/mL for 40 cutaneous squamous cell carcinomas and 10 keratoacanthomas. We describe the characteristics of these patients and calculate the clinical clearance rate of dilute intralesional 5-FU therapy for NMSC at our institution. RESULTS: Dilute intralesional 5-FU successfully treated 96% (48/50) of the study lesions, providing complete clinical clearance in 82% (9/11) of patients across a mean follow-up time of 21.7 months. All patients tolerated their treatments well with no reported adverse effects or local recurrences. DISCUSSION: The use of more dilute preparations of intralesional 5-FU for NMSC may be a means of reducing cumulative dose and dose-dependent adverse reactions while maintaining clinical clearance. J Drugs Dermatol. 2023;22(5): doi:10.36849/JDD.5058.


Asunto(s)
Carcinoma de Células Escamosas , Queratoacantoma , Neoplasias Cutáneas , Humanos , Queratoacantoma/diagnóstico , Queratoacantoma/tratamiento farmacológico , Queratoacantoma/inducido químicamente , Estudios Retrospectivos , Inyecciones Intralesiones , Fluorouracilo , Carcinoma de Células Escamosas/patología , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/inducido químicamente , Resultado del Tratamiento
2.
J Cutan Pathol ; 47(5): 470-474, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31804714

RESUMEN

Crospovidone is an insoluble pharmaceutical disintegrant that has been implicated in a rare foreign body reaction in injection drug users, classically associated with pulmonary angiothrombosis. We recently reported the first known cases of cutaneous crospovidone deposition. We herein report two additional cases with unique clinicopathologic manifestations, both in the setting of suspected injection drug abuse. Additionally, we provide a comprehensive overview of the distinct histomorphology and reproducible histochemistry of crospovidone.


Asunto(s)
Cuerpos Extraños/inducido químicamente , Excipientes Farmacéuticos/efectos adversos , Povidona/efectos adversos , Piel/patología , Adulto , Analgésicos Opioides/administración & dosificación , Analgésicos Opioides/efectos adversos , Buprenorfina/administración & dosificación , Buprenorfina/efectos adversos , Femenino , Cuerpos Extraños/diagnóstico , Humanos , Inyecciones Subcutáneas , Masculino , Trastornos Relacionados con Sustancias/complicaciones , Trastornos Relacionados con Sustancias/diagnóstico
3.
Exp Mol Pathol ; 111: 104320, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31639332

RESUMEN

BRAF V600E is the predominant oncogenic driver of L-group histiocytoses, which includes Erdheim-Chester disease (ECD); however, limited data exist on the prevalence of this mutation in sporadic XG family lesions. This study sought to determine the incidence of BRAF V600E mutation in a clinically annotated cohort of patients with xanthogranulomas (XG) and reticulohistiocytomas (RH). A retrospective review of 58 lesions was performed, including 41 XG and 17 RH. Immunohistochemistry (HC) and PCR-based methods were performed to evaluate for the BRAF V600E mutation. The BRAF V600E mutation was detected by IHC/PCR in 3 RH from an adult who had no history of arthritis, malignancy, xanthelasma, diabetes insipidus or bone pain. All other XG and RH were negative for the BRAF V600E mutation. No associated systemic diseases were identified in this cohort. Our findings suggest that BRAF V600E mutations are not an oncogenic driver of sporadic XG and solitary RH. Therefore, identification of such a mutation in a patient with multiple lesions should raise consideration for ECD. We also report the first known BRAF V600E mutation in a patient with multiple reticulohistiocytomas.


Asunto(s)
Biomarcadores de Tumor/genética , Enfermedad de Erdheim-Chester/genética , Enfermedad de Erdheim-Chester/patología , Mutación , Proteínas Proto-Oncogénicas B-raf/genética , Adolescente , Adulto , Anciano , Carcinogénesis , Niño , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Adulto Joven
4.
Am J Dermatopathol ; 41(8): e84-e86, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31335429

RESUMEN

Crospovidone, a polymer of poly N-vinyl-2-pyrrolidone, is an inert insoluble disintegrant found in pharmaceutical tablets. This material has been encountered in the lungs of intravenous drug users and embolized with other components such as talc and microcrystalline cellulose. More recently, crospovidone has also been described in the gastrointestinal tract. We present 2 cases of cutaneous crospovidone deposition resulting from subcutaneous injection of crushed tablets, commonly known as "skin popping." Clinical presentation includes painful, inflamed papules, nodules, or ulcers with overlying eschar. Crospovidone has a distinct and reproducible histochemical staining profile. Histologic recognition of this material is important because it can guide clinicians in their diagnosis and management decisions.


Asunto(s)
Analgésicos Opioides/efectos adversos , Cuerpos Extraños/etiología , Trastornos Relacionados con Opioides/complicaciones , Excipientes Farmacéuticos/efectos adversos , Povidona/efectos adversos , Piel/química , Abuso de Sustancias por Vía Intravenosa/complicaciones , Adulto , Analgésicos Opioides/análisis , Composición de Medicamentos , Femenino , Cuerpos Extraños/patología , Humanos , Inyecciones Subcutáneas , Excipientes Farmacéuticos/análisis , Povidona/análisis , Piel/patología , Comprimidos
5.
Am J Dermatopathol ; 41(1): 50-54, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29944473

RESUMEN

Testicular choriocarcinoma needs to be considered in the differential diagnosis of cutaneous metastases in young adult men because of its propensity for early hematogenous dissemination. Furthermore, the diagnosis may not be suspected in many cases in which there is clinically no testicular enlargement. This highly aggressive germ cell tumor typically metastasizes to the liver, lungs, and brain. Skin metastasis is exceedingly rare with only 22 cases previously reported in the world literature. We herein report 2 additional cases: a 25-year-old man and a 32-year-old man, both of whom were treated for mixed germ cell tumors and developed multiple cutaneous metastases to the head.


Asunto(s)
Neoplasias Encefálicas/secundario , Coriocarcinoma no Gestacional/secundario , Neoplasias Cutáneas/secundario , Neoplasias Testiculares/patología , Adulto , Biomarcadores de Tumor/sangre , Biopsia , Neoplasias Encefálicas/sangre , Neoplasias Encefálicas/diagnóstico por imagen , Neoplasias Encefálicas/terapia , Coriocarcinoma no Gestacional/sangre , Coriocarcinoma no Gestacional/diagnóstico por imagen , Coriocarcinoma no Gestacional/terapia , Gonadotropina Coriónica/sangre , Humanos , Inmunohistoquímica , Imagen por Resonancia Magnética , Masculino , Neoplasias Cutáneas/sangre , Neoplasias Cutáneas/terapia , Neoplasias Testiculares/sangre , Neoplasias Testiculares/terapia , Resultado del Tratamiento
6.
Mov Disord ; 33(11): 1760-1768, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30306618

RESUMEN

BACKGROUND: Outcome measures that capture functional abilities related to cognition offer the potential to demonstrate real-world effectiveness of cognitive-enhancing treatments. However, distinguishing functional disability related to cognition from that attributed to motor symptoms can be difficult in PD. A performance-based functional assessment allows for direct observation of activity of daily living skills and separation of cognitive from motoric disabilities. OBJECTIVES: Validate the University of California San Diego Performance-Based Skills Assessment in PD. METHODS: One hundred PD participants, ranging from normal cognition to dementia, completed the University of California San Diego Performance-Based Skills Assessment, a performance-based measure of cognitively demanding activities of daily living, as well as a neuropsychological battery and motor examination. Cognitive classification was determined by consensus conference, blinded to University of California San Diego Performance-Based Skills Assessment scores. Psychometric properties of the University of California San Diego Performance-Based Skills Assessment, including internal consistency, test-retest and inter-rater reliability, and discriminant validity for dementia, were examined. RESULTS: The University of California San Diego Performance-Based Skills Assessment demonstrated strong internal consistency (Cronbach's α = 0.82) and test-retest reliability (r = 0.89) and correlated strongly with global cognition (Mattis Dementia Rating Scale: r = 0.80; P < 0.001). University of California San Diego Performance-Based Skills Assessment regression models indicated greater contribution from cognitive explanatory variables (marginal partial: R2 = 0.33) than motor variables (marginal partial: R2 = 0.05), controlling for age, education, disease duration, and l-dopa equivalent dose. Additionally, the University of California San Diego Performance-Based Skills Assessment exhibited strong discriminant validity for dementia (area under the curve = 0.91). CONCLUSIONS: The University of California San Diego Performance-Based Skills Assessment is a valid measure of functional abilities related to cognition rather than motor symptoms in PD. Furthermore, it reliably distinguishes demented from nondemented participants. The University of California San Diego Performance-Based Skills Assessment may be considered as an outcome measure that combines cognitive and functional abilities in treatment trials for cognitive impairment in PD. © 2018 International Parkinson and Movement Disorder Society.


Asunto(s)
Trastornos del Conocimiento/diagnóstico , Trastornos del Conocimiento/etiología , Pruebas Neuropsicológicas , Enfermedad de Parkinson/complicaciones , Actividades Cotidianas/psicología , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedad de Parkinson/psicología , Psicometría , Curva ROC , Análisis de Regresión , Reproducibilidad de los Resultados
8.
J Paediatr Child Health ; 51(8): 815-9, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25643859

RESUMEN

AIM: Recognition of normal and abnormal heart sounds and murmurs is an important but declining clinical skill among practitioners. Current teaching methods are often ineffective. This may result from inadequate repetition and normal-abnormal comparisons needed for auditory recognition. This paper describes a rapid new method of teaching murmur recognition using principles of auditory training. METHODS: Participants were 120 Australian and 42 Canadian medical students. The medical students were randomised to intervention and control (no intervention) groups. The 1-h online programme structured like a computer game used auditory training methodology to teach students to distinguish between innocent and pathological murmurs. Participants underwent pre- and post-testing on 20 paediatric murmurs. Post-testing occurred immediately following training and after 2 months. Twenty-two Canadian medical students were retested 1 year later with a brief mastery-style reinforcement programme. RESULTS: Median pre- and post-test scores improved in about 1 h from 75-95% (P < 0.001) for Australian students and 85-95% (P = 0.004) for Canadian students. Two-month post-test scores declined for Australian students to 85% (P = 0.001), and for Canadian students to 85% (P = 0.02). Australian controls had no significant change during the study period, whereas Canadian controls improved slightly. The group receiving reinforcement after 1 year had a median final score of 90%. CONCLUSIONS: This auditory training programme rapidly teaches students to distinguish innocent and pathological murmurs with at least 90% accuracy. The skill declines within 2 months but can be restored with brief mastery reinforcement 1 year later.


Asunto(s)
Competencia Clínica , Educación a Distancia , Educación de Pregrado en Medicina , Soplos Cardíacos/diagnóstico , Internet , Adulto , Australia , Canadá , Humanos , Internacionalidad , Estudiantes de Medicina , Adulto Joven
9.
Am J Dermatopathol ; 36(8): 609-19, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25051039

RESUMEN

Herpes simplex virus and varicella zoster virus are double-stranded DNA viruses that commonly infect humans, resulting in cutaneous manifestations. Diagnosis is generally made based on clinical findings; however, when the presentation is atypical, biopsy can aid in making a correct diagnosis. The classic histopathological findings of herpetic infection are well established (acantholysis, ballooning degeneration, intranuclear inclusions, multinucleation, necrosis, and formation of vesicles or ulcers). Herpes infection can also cause histopathological changes in many dermal structures. Furthermore, herpes can masquerade as a variety of hematologic malignancies or benign cutaneous conditions. The histopathological spectrum of herpes infections is reviewed and discussed.


Asunto(s)
Herpes Simple/patología , Enfermedades Cutáneas Virales/patología , Piel/patología , Biopsia , Diagnóstico Diferencial , Herpes Simple/virología , Herpesvirus Humano 3/aislamiento & purificación , Herpesvirus Humano 3/patogenicidad , Humanos , Valor Predictivo de las Pruebas , Simplexvirus/aislamiento & purificación , Simplexvirus/patogenicidad , Piel/virología , Enfermedades Cutáneas Virales/virología
10.
Dermatol Online J ; 19(7): 18965, 2013 Jul 14.
Artículo en Inglés | MEDLINE | ID: mdl-24010511

RESUMEN

Molluscum contagiosum is a common cutaneous infection caused by a double-stranded DNA poxvirus. Skin lesions classically present as small, flesh-colored papules with central umbilication. Lesions are frequently seen on the face, trunk, and extremities of children, or on the genitals of young adults as a sexually transmitted infection. Molluscum contagiosum on the nipple or areola has only been previously described in 4 women. We describe a woman with molluscum contagiosum on the left areola and review the clinical characteristics and histological findings of patients who developed molluscum contagiosum of the nipple or areola.


Asunto(s)
Enfermedades de la Mama/patología , Molusco Contagioso/patología , Pezones/patología , Adulto , Enfermedades de la Mama/virología , Femenino , Humanos , Pezones/virología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA